SCHEMBL9105500

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9699823	0.83	MAPT (0.41)	POLBADORA2AADORA1PNPKMT2A
	SCHEMBL10048197	0.82	ADORA2A (0.50)	POLBADORA2AADORA1PNPMEN1
	SCHEMBL9104128	0.81	PLA2G7 (0.41)	POLBADORA2AADORA1PNPPKM
	SCHEMBL9107110	0.80	PLA2G7 (0.46)	ADORA2AADORA1
	SCHEMBL9110081	0.79	CYP3A4 (0.40)	POLBMEN1KMT2A
	SCHEMBL9103190	0.78	PLA2G7 (0.43)	ADORA2AADORA1
	SCHEMBL9106617	0.78	LOXL2 (0.33)	POLBADORA2AADORA1PNP
	SCHEMBL9106375	0.77	ADORA2A (0.34)	POLBADORA2AADORA1
	SCHEMBL7007073	0.67	PLA2G7 (0.49)	ADORA2AADORA1PNPPKM
	SCHEMBL9104605	0.66	L3MBTL1 (0.35)	MEN1KMT2APKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.